WOCKHARDT
|
The Current P/S Ratio of WOCKHARDT is 6.97.
| Share Price | ₹1,291.1 | Oct 30,2025 |
| Market Cap | ₹20,979.6 Cr | |
| Sales-TTM | ₹3,011.0 Cr | TTM-Consolidated Results |
| Price/Sales | 6.97x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of WOCKHARDT
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹20,979.6 Cr] as on Oct 30,2025
(/) Sales [ ₹3,011.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 6.97x ]
Thus, for WOCKHARDT , the investors are currently willing to pay '6.97 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WOCKHARDT !
The chart below summarizes the trend in P/S Ratio of WOCKHARDT over the last five years.
Historical PS (Price/Sales) ratio chart of WOCKHARDT
PS Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.91x.
- WOCKHARDT 's operated at median p/e ratio of 1.68x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/e ratio peaked in Mar2025 at 7.66x.
- WOCKHARDT 's p/e ratio hit its five-year low in Mar2023 of 0.84x.
How does WOCKHARDT 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| WOCKHARDT | 3,011.0 | 6.97 | 20,979.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.60 | 408,751.0 |
| DIVIS LABORATORIES LTD | 9,652.0 | 18.30 | 176,634.0 |
| CIPLA LTD | 28,349.6 | 4.39 | 124,437.0 |
| TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.30 | 121,871.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.92 | 100,333.0 |
| MANKIND PHARMA LTD | 12,956.2 | 7.79 | 100,950.0 |
| ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.20 | 99,244.9 |
| LUPIN LTD | 23,375.9 | 3.80 | 88,847.7 |
| AUROBINDO PHARMA LTD | 32,024.8 | 2.00 | 64,033.4 |
| ABBOTT INDIA LTD | 6,589.9 | 9.56 | 62,972.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WOCKHARDT 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.00x |
| Max industry PS | 18.30x |
| Median industry PS | 6.97x |
| Average industry PS | 7.08x |
You may also like the below Video Courses